AMRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Amneal Pharmaceuticals Inc (AMRX).


$2.45B Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

AMRX Market Cap. (MRY)


AMRX Shares Outstanding (MRY)


AMRX Assets (MRY)


Total Assets

$3.50B

Total Liabilities

$3.61B

Total Investments

$0

AMRX Income (MRY)


Revenue

$2.79B

Net Income

-$116.89M

Operating Expense

$772.04M

AMRX Cash Flow (MRY)


CF Operations

$295.10M

CF Investing

-$63.00M

CF Financing

-$211.79M

AMRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AMRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,501,445,000 (0.83%)

$3,472,569,000 (-8.60%)

$3,799,341,000 (-3.56%)

$3,939,664,000 (-1.66%)

Assets Current

$1,587,806,000 (15.24%)

$1,377,863,000 (-2.41%)

$1,411,818,000 (-7.12%)

$1,520,108,000 (-2.03%)

Assets Non-Current

$1,913,639,000 (-8.64%)

$2,094,706,000 (-12.26%)

$2,387,523,000 (-1.32%)

$2,419,556,000 (-1.42%)

Goodwill & Intangible Assets

$1,329,813,000 (-10.69%)

$1,489,052,000 (-12.15%)

$1,694,946,000 (-3.69%)

$1,759,939,000 (-3.69%)

Shareholders Equity

-$109,267,000 (-652.38%)

$19,781,000 (-93.37%)

$298,421,000 (-17.18%)

$360,340,000 (18.82%)

Property Plant & Equipment Net

$523,693,000 (-4.81%)

$550,137,000 (-6.66%)

$589,360,000 (-7.77%)

$639,003,000 (5.67%)

Cash & Equivalents

$118,420,000 (19.49%)

$99,107,000 (181.34%)

$35,227,000 (-86.28%)

$256,739,000 (-26.04%)

Accumulated Other Comprehensive Income

-$65,510,000 (-102.51%)

-$32,349,000 (-425.48%)

$9,939,000 (140.03%)

-$24,827,000 (39.91%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$612,454,000 (5.34%)

$581,384,000 (9.54%)

$530,735,000 (8.45%)

$489,389,000 (-0.26%)

Trade & Non-Trade Receivables

$776,215,000 (26.28%)

$614,687,000 (-17.19%)

$742,291,000 (11.83%)

$663,762,000 (3.66%)

Trade & Non-Trade Payables

$786,350,000 (43.90%)

$546,438,000 (-0.26%)

$547,848,000 (2.41%)

$534,964,000 (-12.79%)

Accumulated Retained Earnings (Deficit)

-$607,062,000 (-23.85%)

-$490,176,000 (-20.68%)

-$406,183,000 (-47.06%)

-$276,197,000 (3.70%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,593,139,000 (-5.72%)

$2,750,523,000 (-3.33%)

$2,845,135,000 (-1.08%)

$2,876,056,000 (-2.34%)

Debt Current

$340,255,000 (49.48%)

$227,624,000 (117.53%)

$104,639,000 (127.29%)

$46,037,000 (-19.90%)

Debt Non-Current

$2,252,884,000 (-10.70%)

$2,522,899,000 (-7.94%)

$2,740,496,000 (-3.16%)

$2,830,019,000 (-1.99%)

Total Liabilities

$3,610,957,000 (4.59%)

$3,452,558,000 (-4.50%)

$3,615,362,000 (1.19%)

$3,572,691,000 (-2.41%)

Liabilities Current

$1,129,771,000 (33.45%)

$846,595,000 (12.46%)

$752,800,000 (11.16%)

$677,243,000 (0.05%)

Liabilities Non-Current

$2,481,186,000 (-4.79%)

$2,605,963,000 (-8.96%)

$2,862,562,000 (-1.14%)

$2,895,448,000 (-2.97%)

AMRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,793,957,000 (16.73%)

$2,393,607,000 (8.20%)

$2,212,304,000 (5.67%)

$2,093,669,000 (5.08%)

Cost of Revenue

$1,773,519,000 (12.74%)

$1,573,042,000 (10.19%)

$1,427,596,000 (7.77%)

$1,324,696,000 (-2.89%)

Selling General & Administrative Expense

$476,436,000 (10.88%)

$429,675,000 (7.50%)

$399,700,000 (9.36%)

$365,504,000 (11.87%)

Research & Development Expense

$190,714,000 (16.32%)

$163,950,000 (-16.22%)

$195,688,000 (-3.05%)

$201,847,000 (12.18%)

Operating Expenses

$772,042,000 (22.41%)

$630,688,000 (-28.24%)

$878,905,000 (42.67%)

$616,057,000 (14.67%)

Interest Expense

$258,595,000 (22.77%)

$210,629,000 (32.99%)

$158,377,000 (16.18%)

$136,325,000 (-6.63%)

Income Tax Expense

$18,863,000 (123.18%)

$8,452,000 (26.87%)

$6,662,000 (-40.50%)

$11,196,000 (110.73%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$73,876,000 (-51.63%)

-$48,722,000 (80.88%)

-$254,789,000 (-1363.21%)

$20,170,000 (-70.59%)

Net Income to Non-Controlling Interests

$43,010,000 (21.94%)

$35,271,000 (128.26%)

-$124,803,000 (-1407.39%)

$9,546,000 (142.46%)

Net Income

-$116,886,000 (-39.16%)

-$83,993,000 (35.38%)

-$129,986,000 (-1323.51%)

$10,624,000 (-88.33%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$116,886,000 (-39.16%)

-$83,993,000 (35.38%)

-$129,986,000 (-1323.51%)

$10,624,000 (-88.33%)

Weighted Average Shares

$308,978,000 (75.42%)

$176,136,000 (16.69%)

$150,944,000 (1.36%)

$148,922,000 (1.00%)

Weighted Average Shares Diluted

$308,978,000 (75.42%)

$176,136,000 (16.69%)

$150,944,000 (-0.58%)

$151,821,000 (1.95%)

Earning Before Interest & Taxes (EBIT)

$160,572,000 (18.86%)

$135,088,000 (285.38%)

$35,053,000 (-77.83%)

$158,145,000 (19.18%)

Gross Profit

$1,020,438,000 (24.36%)

$820,565,000 (4.57%)

$784,708,000 (2.05%)

$768,973,000 (22.37%)

Operating Income

$248,396,000 (30.82%)

$189,877,000 (301.57%)

-$94,197,000 (-161.60%)

$152,916,000 (67.75%)

AMRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$62,996,000 (8.95%)

-$69,189,000 (60.31%)

-$174,309,000 (10.23%)

-$194,182,000 (38.85%)

Net Cash Flow from Financing

-$211,791,000 (0.37%)

-$212,573,000 (-99.37%)

-$106,620,000 (22.81%)

-$138,122,000 (-204.79%)

Net Cash Flow from Operations

$295,099,000 (-14.61%)

$345,577,000 (430.84%)

$65,100,000 (-73.08%)

$241,820,000 (-36.20%)

Net Cash Flow / Change in Cash & Cash Equivalents

$19,313,000 (-69.77%)

$63,880,000 (128.84%)

-$221,512,000 (-145.08%)

-$90,382,000 (-146.52%)

Net Cash Flow - Business Acquisitions and Disposals

$11,994,000 (0%)

$0 (0%)

-$84,714,000 (42.19%)

-$146,543,000 (41.70%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$60,340,000 (-28.93%)

-$46,801,000 (4.09%)

-$48,795,000 (4.21%)

-$50,939,000 (17.62%)

Issuance (Repayment) of Debt Securities

-$185,189,000 (-917.54%)

$22,652,000 (159.19%)

-$38,272,000 (51.66%)

-$79,179,000 (-155.37%)

Issuance (Purchase) of Equity Shares

$1,154,000 (155.88%)

$451,000 (-31.87%)

$662,000 (-22.39%)

$853,000 (165.73%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$999,000 (-1636.92%)

$65,000 (101.14%)

-$5,683,000 (-5671.57%)

$102,000 (-90.16%)

Share Based Compensation

$27,768,000 (3.53%)

$26,822,000 (-15.78%)

$31,847,000 (12.09%)

$28,412,000 (36.93%)

Depreciation Amortization & Accretion

$236,191,000 (2.96%)

$229,400,000 (-4.49%)

$240,175,000 (2.90%)

$233,406,000 (-0.84%)

AMRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

36.50% (6.41%)

34.30% (-3.38%)

35.50% (-3.27%)

36.70% (16.51%)

Profit Margin

-4.20% (-20.00%)

-3.50% (40.68%)

-5.90% (-1280.00%)

0.50% (-89.13%)

EBITDA Margin

14.20% (-6.58%)

15.20% (22.58%)

12.40% (-33.69%)

18.70% (1.08%)

Return on Average Equity (ROAE)

144.40% (513.75%)

-34.90% (14.88%)

-41.00% (-1422.58%)

3.10% (-89.53%)

Return on Average Assets (ROAA)

-3.40% (-47.83%)

-2.30% (30.30%)

-3.30% (-1200.00%)

0.30% (-86.36%)

Return on Sales (ROS)

5.70% (1.79%)

5.60% (250.00%)

1.60% (-78.95%)

7.60% (13.43%)

Return on Invested Capital (ROIC)

4.40% (29.41%)

3.40% (277.78%)

0.90% (-76.92%)

3.90% (21.87%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-20.84 (-64.81%)

-12.65 (-446.50%)

-2.31 (-103.38%)

68.43 (828.35%)

Price to Sales Ratio (P/S)

0.88 (95.97%)

0.45 (228.68%)

0.14 (-60.12%)

0.34 (0.89%)

Price to Book Ratio (P/B)

-22.46 (-123.87%)

94.07 (4547.53%)

2.02 (-49.50%)

4.01 (-11.27%)

Debt to Equity Ratio (D/E)

-33.05 (-118.93%)

174.54 (1340.69%)

12.12 (22.19%)

9.91 (-17.87%)

Earnings Per Share (EPS)

-0.38 (20.83%)

-0.48 (44.19%)

-0.86 (-1328.57%)

0.07 (-88.71%)

Sales Per Share (SPS)

9.04 (-33.46%)

13.59 (-7.27%)

14.66 (4.25%)

14.06 (4.03%)

Free Cash Flow Per Share (FCFPS)

0.76 (-55.19%)

1.7 (1470.37%)

0.11 (-91.58%)

1.28 (-40.40%)

Book Value Per Share (BVPS)

-0.35 (-416.07%)

0.11 (-94.33%)

1.98 (-18.31%)

2.42 (17.65%)

Tangible Assets Book Value Per Share (TABVPS)

7.03 (-37.59%)

11.26 (-19.23%)

13.94 (-4.75%)

14.64 (-0.94%)

Enterprise Value Over EBIT (EV/EBIT)

31 (-8.82%)

34 (-64.58%)

96 (284.00%)

25 (-16.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

12.65 (0.92%)

12.54 (2.53%)

12.23 (19.19%)

10.26 (-6.63%)

Asset Turnover

0.8 (21.33%)

0.66 (16.58%)

0.57 (7.59%)

0.53 (9.11%)

Current Ratio

1.41 (-13.70%)

1.63 (-13.17%)

1.88 (-16.48%)

2.25 (-2.05%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$234,759,000 (-21.43%)

$298,776,000 (1732.42%)

$16,305,000 (-91.46%)

$190,881,000 (-39.82%)

Enterprise Value (EV)

$5,020,283,886 (9.86%)

$4,569,804,288 (35.78%)

$3,365,656,431 (-16.22%)

$4,017,245,694 (-0.68%)

Earnings Before Tax (EBT)

-$98,023,000 (-29.76%)

-$75,541,000 (38.75%)

-$123,324,000 (-665.19%)

$21,820,000 (264.07%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$396,763,000 (8.85%)

$364,488,000 (32.43%)

$275,228,000 (-29.71%)

$391,551,000 (6.37%)

Invested Capital

$3,516,580,000 (-7.17%)

$3,788,338,000 (-8.97%)

$4,161,503,000 (0.96%)

$4,121,799,000 (0.54%)

Working Capital

$458,035,000 (-13.78%)

$531,268,000 (-19.38%)

$659,018,000 (-21.81%)

$842,865,000 (-3.63%)

Tangible Asset Value

$2,171,632,000 (9.48%)

$1,983,517,000 (-5.74%)

$2,104,395,000 (-3.46%)

$2,179,725,000 (0.05%)

Market Capitalization

$2,453,967,886 (31.88%)

$1,860,723,288 (207.99%)

$604,149,431 (-58.17%)

$1,444,128,694 (5.42%)

Average Equity

-$80,972,000 (-133.63%)

$240,806,000 (-24.00%)

$316,835,500 (-8.16%)

$344,992,000 (12.31%)

Average Assets

$3,482,185,500 (-3.85%)

$3,621,784,750 (-7.16%)

$3,900,938,250 (-1.85%)

$3,974,299,000 (-3.60%)

Invested Capital Average

$3,645,290,250 (-8.10%)

$3,966,613,000 (-3.18%)

$4,097,028,250 (0.25%)

$4,086,699,500 (-2.29%)

Shares

309,844,430 (1.08%)

306,544,199 (0.97%)

303,592,679 (0.70%)

301,488,245 (0.58%)